Drug resistance of tuberculosis patients at the makassar city community lung health center hospital: Case Study
Abstract
Introduction: Drug-resistant tuberculosis (TB-RO) is still a health problem because of its rapid transmission with an increasing number of cases.
Objective: This study aims to discover in-depth patient knowledge about tuberculosis and the family's role in treating drug-resistant tuberculosis patients.
Methods: This research uses a qualitative case study approach with nine informants. The selection of informants was determined using a purposive sampling technique. Data collection was obtained through interviews and observations. Data analysis was carried out qualitatively.
Result: The research shows that informants' knowledge about drug-resistant tuberculosis depends on their educational history. In contrast, informants with low educational backgrounds only know the term tuberculosis but do not know the causes and dangers of drug-resistant tuberculosis. Another thing that was found was that the family also played a role in the patient's treatment by providing support and encouragement for the informant during the treatment period.
Conclusion: This research concludes that the informant's knowledge about tuberculosis plays an essential role in the occurrence of drug-resistant tuberculosis. The role of the family does not contribute to the occurrence of drug-resistant tuberculosis in the informant. It can be concluded that the earlier the age of menarche increases the risk of uterine myoma later in life. In contrast, slower menarche may be associated with a reduced risk of myomas. Other factors such as genetic, environmental, and lifestyle factors also influence the incidence of uterine myomas, but menarche age is one of the significant hormonal indicators of risk.
Downloads
References
Bokolia, N. P. et al. (2024) ‘A novel C-4-modified isotetrone acts as a potent bio-enhancer to augment the activities of anti-tuberculosis drugs against Mycobacterium tuberculosis’, Tuberculosis, p. 102569. doi: https://doi.org/10.1016/j.tube.2024.102569.
Derendinger, B. et al. (2023) ‘Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort study’, The Lancet Microbe, 4(12), pp. e972–e982. doi: https://doi.org/10.1016/S2666-5247(23)00172-6.
Desikan, P. et al. (2024) ‘Trends of drug resistance in M. tuberculosis in a reference laboratory in Central India: Forging ahead towards TB elimination’, Indian Journal of Medical Microbiology, 51, p. 100701. doi: https://doi.org/10.1016/j.ijmmb.2024.100701.
Du, W. et al. (2024) ‘Association of bacteriomes with drug susceptibility in lesions of pulmonary tuberculosis patients’, Heliyon, 10(18), p. e37583. doi: https://doi.org/10.1016/j.heliyon.2024.e37583.
Duwairi, R. and Melhem, A. (2023) ‘A deep learning-based framework for automatic detection of drug resistance in tuberculosis patients’, Egyptian Informatics Journal, 24(1), pp. 139–148. doi: https://doi.org/10.1016/j.eij.2023.01.002.
Fan, Y. F. et al. (2024) ‘Inferring Mycobacterium Tuberculosis Drug Resistance and Transmission using Whole-genome Sequencing in a High TB-burden Setting in China’, Biomedical and Environmental Sciences, 37(2), pp. 157–169. doi: https://doi.org/10.3967/bes2023.116.
Hasan, Z. et al. (2024) ‘Efflux pump gene single-nucleotide variants associated with resistance in Mycobacterium tuberculosis isolates with discrepant drug genotypes’, Journal of Global Antimicrobial Resistance, 38, pp. 128–139. doi: https://doi.org/10.1016/j.jgar.2024.05.006.
Hikmawati, H., Muhsina, S. and Amandaty, S. (2023) ‘Knowledge and Perceptions of Coastal Adolescents on TB and HIV/AIDS’, Jurnal Ilmiah Kesehatan Sandi Husada, 12(2 SE-Book Review). doi: https://doi.org/10.35816/jiskh.v12i2.1170.
Iswanti, F. C. et al. (2024) ‘Lysosomal enzymes and the oxygen burst capability of monocyte-derived macrophages in active drug-resistant tuberculosis patients in relation to cell attachment’, Tuberculosis, 146, p. 102498. doi: https://doi.org/10.1016/j.tube.2024.102498.
Jin, C. et al. (2024) ‘Prevalence and patterns of drug-resistant Mycobacterium tuberculosis in newly diagnosed patients in China: A systematic review and meta-analysis’, Journal of Global Antimicrobial Resistance, 38, pp. 292–301. doi: https://doi.org/10.1016/j.jgar.2024.05.018.
Lina Yunita et al. (2023) ‘Efektif Pengetahuan dan Sikap Masyarakat Dalam Upaya Pencegahan Tuberkulosis’, Journal of Health (JoH), 10(2), pp. 186–193. doi: https://doi.org/10.30590/joh.v10n2.619.
Madaki, S. et al. (2024) ‘Age and gender in drug resistance tuberculosis: a cross sectional case study at a national tuberculosis reference hospital in Nigeria’, Journal of Global Antimicrobial Resistance. doi: https://doi.org/10.1016/j.jgar.2024.09.002.
Messah, A. D. V. et al. (2024) ‘Correlation between Gene polymorphism levels of serum matrix metalloproteinases with cavitary features and pulmonary fibrosis of the Patient tuberculosis multi-drug resistance using high-resolution computerized tomography of the Thorax’, Heliyon, 10(13), p. e33671. doi: https://doi.org/10.1016/j.heliyon.2024.e33671.
Mokrousov, I. et al. (2024) ‘Increasing circulation of multi-drug resistant tuberculosis strains in Buryatia, high-burden and ethnically diverse region in the Russian Far East’, Tuberculosis, 149, p. 102555. doi: https://doi.org/10.1016/j.tube.2024.102555.
Muda, M. R. et al. (2024) ‘A time-to-event modelling of sputum conversion within two months after antituberculosis initiation among drug-susceptible smear positive pulmonary tuberculosis patients: Implementation of internal and external validation’, Tuberculosis, 148, p. 102553. doi: https://doi.org/10.1016/j.tube.2024.102553.
Okumu, A. et al. (2024) ‘Factors associated with tuberculosis drug resistance among presumptive multidrug resistance tuberculosis patients identified in a DRTB surveillance study in western Kenya’, Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 37, p. 100466. doi: https://doi.org/10.1016/j.jctube.2024.100466.
Prommi, A. et al. (2024) ‘Co-resistance to isoniazid and second-line anti-tuberculosis drugs in isoniazid-resistant tuberculosis at a tertiary care hospital in Thailand’, Microbiology Spectrum, 12(3). doi: https://doi.org/10.1128/spectrum.03462-23.
Rao, M. et al. (2023) ‘Lineage classification and antitubercular drug resistance surveillance of Mycobacterium tuberculosis by whole-genome sequencing in Southern India’, Microbiology Spectrum. Edited by H. H. Mostafa, 11(5). doi: https://doi.org/10.1128/spectrum.04531-22.
Sanchini, A. et al. (2024) ‘Exploring diagnostic methods for drug-resistant tuberculosis: A comprehensive overview’, Tuberculosis, 148, p. 102522. doi: https://doi.org/10.1016/j.tube.2024.102522.
Schwab, T. C. et al. (2024) ‘Targeted next-generation sequencing to diagnose drug-resistant tuberculosis: a systematic review and meta-analysis’, The Lancet Infectious Diseases, 24(10), pp. 1162–1176. doi: https://doi.org/10.1016/S1473-3099(24)00263-9.
Simsek, E. et al. (2024) ‘A Rapid and Simple Modified Nitrate Reductase Assay for Testing First and Second-line Antituberculosis Drug Susceptibilities in Mycobacterium tuberculosis Isolates’, Diagnostic Microbiology and Infectious Disease, p. 116547. doi: https://doi.org/10.1016/j.diagmicrobio.2024.116547.
de Vos, M. et al. (2024) ‘Accuracy of cobas MTB and MTB-RIF/INH for Detection of Mycobacterium tuberculosis and Drug Resistance’, The Journal of Molecular Diagnostics, 26(8), pp. 708–718. doi: https://doi.org/10.1016/j.jmoldx.2024.05.004.
Wang, Y. et al. (2023) ‘Clinical performance of nucleotide MALDI-TOF-MS in the rapid diagnosis of pulmonary tuberculosis and drug resistance’, Tuberculosis, 143, p. 102411. doi: https://doi.org/10.1016/j.tube.2023.102411.
Wei, X. et al. (2024) ‘Recent advances and challenges of revolutionizing drug-resistant tuberculosis treatment’, European Journal of Medicinal Chemistry, 277, p. 116785. doi: https://doi.org/10.1016/j.ejmech.2024.116785.
Zhang, G. et al. (2024) ‘Genetic factors associated with acquired phenotypic drug resistance and its compensatory evolution during tuberculosis treatment’, Clinical Microbiology and Infection, 30(5), pp. 637–645. doi: https://doi.org/10.1016/j.cmi.2024.01.016.
